Karine Auclair

Dr. Auclair is a notable bioorganic chemist renowned for her groundbreaking work in combating antibiotic resistance through innovative approaches. With a focus on addressing the escalating threat of untreatable bacterial infections, Dr. Auclair's research aims to bridge the gap in antibiotic development by proposing alternative treatments that target bacteria without traditional antibiotics. By inhibiting bacterial itaconate-degrading enzymes, her work has demonstrated the ability to sensitize bacteria to natural antimicrobials produced by mammalian macrophages, leading to significant reductions in bacterial proliferation. With a prolific academic career spanning from the University of Alberta to McGill University, Dr. Auclair holds the Canada Research Chair in Antimicrobials and Green Enzyme, showcasing her expertise and leadership in the field. Through numerous awards, patents, and over a hundred peer-reviewed publications, Dr. Auclair continues to make invaluable contributions to combatting antibiotic resistance on a global scale.